{"id":2489,"date":"2015-10-14T03:30:47","date_gmt":"2015-10-14T03:30:47","guid":{"rendered":"http:\/\/www.kurzweilai.net\/?p=264802"},"modified":"2015-10-14T03:30:47","modified_gmt":"2015-10-14T03:30:47","slug":"fda-approves-the-first-3d-printed-drug-product","status":"publish","type":"post","link":"https:\/\/hoo.central12.com\/fugic\/2015\/10\/14\/fda-approves-the-first-3d-printed-drug-product\/","title":{"rendered":"FDA approves the first 3D-printed drug product"},"content":{"rendered":"<div id=\"attachment_264811\" class=\"wp-caption aligncenter\" style=\"width: 605px;  border: 1px solid #dddddd; background-color: #f3f3f3; padding-top: 4px; margin: 10px; text-align:center; display: block; margin-right: auto; margin-left: auto;\"><a href=\"http:\/\/www.kurzweilai.net\/fda-approves-the-first-3d-printed-drug-product\/zipdose-3d-printing\" rel=\"attachment wp-att-264811\"><img class=\" wp-image-264811\" title=\"ZipDose 3D Printing\" src=\"http:\/\/www.kurzweilai.net\/images\/ZipDose-3D-Printing.jpg\" alt=\"\" width=\"595\" height=\"358\" \/><\/a><p style=' padding: 0 4px 5px; margin: 0;'  class=\"wp-caption-text\">How ZipDose Technology works. The result is a porous drug product that disintegrates with just a sip of liquid. (credit: Aprecia Pharmaceuticals Company)<\/p><\/div>\n<p>The FDA has approved the first 3D-printed drug &#8212; Aprecia\u2019s SPRITAM (levetiracetam) for oral use as a prescription adjunctive therapy in the treatment of seizures in adults and children with epilepsy.<\/p>\n<p>SPRITAM manufacturing uses 3D printing to produce a porous formulation that rapidly disintegrates with a sip of liquid, making it easier to swallow.<\/p>\n<div id=\"attachment_264814\" class=\"wp-caption aligncenter\" style=\"width: 352px;  border: 1px solid #dddddd; background-color: #f3f3f3; padding-top: 4px; margin: 10px; text-align:center; display: block; margin-right: auto; margin-left: auto;\"><a href=\"http:\/\/www.kurzweilai.net\/fda-approves-the-first-3d-printed-drug-product\/spritam-product-shot\" rel=\"attachment wp-att-264814\"><img class=\"size-full wp-image-264814 \" title=\"Spritam Product Shot\" src=\"http:\/\/www.kurzweilai.net\/images\/Spritam-Product-Shot.jpg\" alt=\"\" width=\"342\" height=\"242\" \/><\/a><p style=' padding: 0 4px 5px; margin: 0;'  class=\"wp-caption-text\">SPRITAM\u00ae levetiracetam, for oral use: 750 mg (foreground) and 1000 mg (background) (credit: Aprecia Pharmaceuticals Company)<\/p><\/div>\n<p>The &#8220;ZipDose Technology&#8221; allows for delivering a high drug load, up to 1,000 mg in a single dose, which is expected to help patients take their medication as prescribed. SPRITAM is expected to be available in the first quarter of 2016.<\/p>\n<p>Nearly three million people in the United States have been diagnosed with active epilepsy, with an estimated 460,000 of those cases occurring in children.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA has approved the first 3D-printed drug &mdash; Aprecia&rsquo;s SPRITAM (levetiracetam) for oral use as a prescription adjunctive therapy in the treatment of seizures in adults and children with epilepsy. SPRITAM manufacturing uses 3D printing to produce a porous formulation that rapidly disintegrates with a sip of liquid, making it easier to swallow. The [&#8230;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,55,43],"tags":[],"class_list":["post-2489","post","type-post","status-publish","format-standard","hentry","category-biotech","category-nanotechmaterials-science","category-news"],"_links":{"self":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/2489"}],"collection":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/comments?post=2489"}],"version-history":[{"count":1,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/2489\/revisions"}],"predecessor-version":[{"id":2490,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/2489\/revisions\/2490"}],"wp:attachment":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/media?parent=2489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/categories?post=2489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/tags?post=2489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}